UnknownNot Applicable

Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C

China116 participantsStarted 2016-02

Plain-language summary

The purpose of this randomized clinical trial is to compare the efficacy and safety of intraoperative mitomycin C(MMC) combined with limbal conjunctival autograft(LCAG) or conjunctival autograft(CAG) for recurrent pterygium surgery. The investigators will also evaluate particular risk factors related to pterygium recurrence

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Recurrent pterygium * Willingness to participate in research project and to attend research time * At least 6 months after last pterygium surgery Exclusion Criteria: * Pregnant,breast-feeding women or poor general health * Patients with significant ocular or lid pathology, such as Sjogren's Syndrome ,infection, exposure keratitis,glaucoma and trauma * Patients with allergy to mitomycin C,tobramycin or local anesthetics

What they're measuring

Recurrence of pterygium

Timeframe: One year

Trial details

NCT IDNCT04463901

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07

Contact for this trial

Zhou Shiyou, M.D., Ph.D.

86-02087331540 zhoushiy@mail.sysu.edu.cn

View on ClinicalTrials.gov More Recurrent Pterygium trials